We are live on
!
Find out more
NC
Nicholas Company Portfolio holdings
AUM
$5.1B
1-Year Est. Return
8.43%
This Fund
S&P 500
This Quarter
Est. Return
-3.15%
1 Year Est. Return
+8.43%
3 Year Est. Return
+54.31%
5 Year Est. Return
+77.46%
10 Year Est. Return
+337.16%
AUM
$5B
AUM Growth
-$230M
(-4.4%)
Cap. Flow
-$29.8M
Cap. Flow
% of AUM
-0.6%
Top 10 Holdings %
Top 10 Hldgs %
20.01%
Holding
221
New
4
Increased
43
Reduced
107
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Stryker
SYK
|
+$43.4M |
| 2 |
DexCom
DXCM
|
+$31.1M |
| 3 |
Texas Instruments
TXN
|
+$11.8M |
| 4 |
Bio-Techne
TECH
|
+$11.3M |
| 5 |
Globus Medical
GMED
|
+$7.15M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$42.5M |
| 2 |
Copart
CPRT
|
+$12.4M |
| 3 |
Insulet
PODD
|
+$12.1M |
| 4 |
Twilio
TWLO
|
+$10.1M |
| 5 |
Cintas
CTAS
|
+$8.88M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.98% |
| 2 | Healthcare | 17.02% |
| 3 | Consumer Discretionary | 12.67% |
| 4 | Industrials | 12.3% |
| 5 | Financials | 10.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Kenvue
KVUE
$38B
| $3.64M | 0.07% |
+181,235
| New | +$4.2M |
|
|
MDC
202
DELISTED
M.D.C. Holdings, Inc.
MDC
| $3.62M | 0.07% |
87,735
-305
| -0.3% | -$14.2K |
|
203
Neogen
NEOG
$2.05B
| $3.59M | 0.07% |
+193,792
| New | +$4.22M |
|
|
NXRT
204
NexPoint Residential Trust
NXRT
$689M
| $3.57M | 0.07% |
110,960
+25
| +0% | +$985 |
|
205
UFP Technologies
UFPT
$1.97B
| $3.48M | 0.07% |
21,556
-30
| -0.1% | -$5.25K |
|
206
Oracle
ORCL
$339B
| $3.37M | 0.07% |
31,835
+5,750
| +22% | +$666K |
|
207
Murphy USA
MUSA
$11.4B
| $3.14M | 0.06% |
9,200
-1,320
| -13% | -$419K |
|
208
Lockheed Martin
LMT
$131B
| $2.67M | 0.05% |
6,520
-25
| -0.4% | -$11.1K |
|
|
ABCM
209
DELISTED
Abcam PLC
ABCM
| $2.01M | 0.04% |
88,635
| – | – |
|
210
US Bancorp
USB
$97.9B
| $1.93M | 0.04% |
58,305
-305
| -0.5% | -$11.1K |
|
211
Genpact
G
$6.22B
| $1.49M | 0.03% |
+41,035
| New | +$1.52M |
|
212
Williams Companies
WMB
$85.8B
| $682K | 0.01% |
20,248
-80
| -0.4% | -$2.73K |
|
213
Cedar Fair
FUN
$1.88B
| $320K | 0.01% |
8,646
| – | – |
|
|
214
Twilio
TWLO
$28.6B
| $213K | ﹤0.01% |
3,635
-161,652
| -98% | -$10.1M |
|
215
Glacier Bancorp
GBCI
$6.36B
| – | – |
-122,120
| Closed | -$3.81M |
|
|
216
Insulet
PODD
$11.8B
| – | – |
-41,816
| Closed | -$12.1M |
|
217
Smith & Nephew
SNN
$13.7B
| – | – |
-151,165
| Closed | -$4.88M |
|
218
Truist Financial
TFC
$63.9B
| – | – |
-975
| Closed | -$29.6K |
|
219
Travel + Leisure Co
TNL
$4.76B
| – | – |
-15,000
| Closed | -$605K |
|
220
Petco
WOOF
$797M
| – | – |
-510,980
| Closed | -$4.55M |
|
|
NUVA
221
DELISTED
NuVasive, Inc.
NUVA
| – | – |
-125,815
| Closed | -$5.23M |
|
Similar funds
VT
CS
EIC
AC
CIA
TAM
CTC
BG
Nicholas Company's Q3 2023 Portfolio in Review
As of Q3 2023, Nicholas Company held 221 positions worth $5B, down 4.4% from $5.23B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Trading was light in Q3 2023: portfolio turnover was 5%. Nicholas Company opened 4 new positions and exited 7, leaving the 221-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Nicholas Company's largest Q3 2023 buy was Stryker: 151,415 shares worth $41.4M.
- Nicholas Company added most to DexCom in Q3 2023, an estimated $31.1M increase.
- Nicholas Company's biggest Q3 2023 reduction was Medtronic, cutting an estimated $42.5M.
- Nicholas Company fully exited Insulet in Q3 2023, selling an estimated $12.1M.
- Nicholas Company's ten largest holdings make up 20% of its $5B portfolio in Q3 2023.
- Nicholas Company opened 4 new positions and closed 7 in Q3 2023.
- Nicholas Company's portfolio value fell 4.4% quarter-over-quarter to $5B.
Based on Nicholas Company's 13F filing for Q3 2023, filed 13 Nov 2023.